Infinite Epigenetics Acquires Tally Health to Build Epigenetic Data Platform for Longevity

Infinite Epigenetics Acquires Tally Health to Build Epigenetic Data Platform for Longevity Infinite Epigenetics, the parent company of TruDiagnostic, has acquired Tally Health, the consumer longevity company co-founded by Harvard geneticist Dr. David Sinclair, in what the company says is the largest acquisition in epigenetic age testing to date. Read More from the Global Wellness News ™

Women’s health market: $600B by 2030 | The UK’s sweeping smoking ban | Biggest sustainability trends in travel for 2026

Headlines in the Global Wellness Economy Global Wellness News™ | April 28th, 2026 Women’s Health to Hit $600B in Shift to Lifelong Care The category is evolving to include conditions that affect women uniquely, disproportionately, and differently from men. What to Know About the U.K.’s Generational Smoking Ban Those in the U.K. born in 2009 and after will never be able to buy cigarettes. The…

New study: Americans spending more on prevention | Hair care is the new longevity play | European fitness market reaches $45B, with much room to grow

Headlines in the Global Wellness Economy Global Wellness News™ | April 23rd, 2026 Hair Care Goes Clinical as Longevity Drives New Protocols As longevity and beauty converge, brands are turning hair health and noninvasive scalp care into a structured system. How Menopause and Longevity Are Reshaping the Industry Midlife beauty is shifting toward healthspan, longevity, and menopause care-driving new opportunities in biotech, diagnostics, and personalized…